DOSE-DIFFERENTIATED CORRELATION INTERACTIONS BETWEEN INDICES OF HEMOGLOBIN EXCHANGE IN TURKEYS UNDER THE INFLUENCE OF THE PROBIOTIC FORMULATION VETOM 1.2

The effect of the probiotic preparation Vetom 1.2 on the basis of Bacillus subtilis VKPM B-10641, Bacillus amyloliquefaciens VKPM B-10642 and Bacillus amyloliquefaciens VKPM B-10643 in different doses on the correlation interactions between the parameters of turkey hemoglobin exchange, blood erythrocytes and blood red blood cells direct and total bilirubin, total protein and serum albumin was studies. Correlations were calculated using Spearman formula, the reliability of correlations was checked by Student. The formulation was used for turkeys once a day for 30 days in doses of 12.5; 25; fifty; 75 and 100 mg / kg body weight. It was found that Vetom 1.2 in minimal doses leads to an inverse correlation between iron and total bilirubin, direct bilirubin, total protein and albumin, an increase in the concentration of the formulation leads to the disappearance of this effect with a gradual subsequent decrease in this indicator. Vetom 1.2 in doses up to 50 mg / kg leads to an inverse correlation between the concentrations of hemoglobin and direct bilirubin, total protein and serum albumin, at a dose of 75 mg / kg there is a direct correlation between these indicators, and at a dose of 100 mg / kg returns a negative correlation. The probiotic preparation Vetom 1.2 leads to a direct dependence of the concentration of bilirubins (total and direct) in serum on the concentrations of hemoglobin and red blood cells when used in most doses, except 75 mg / kg, which reduces the correlation.

total bilirubin, direct bilirubin, Vetom 1.2, hemoglobin, dose, iron, turkeys, correlation, probiotic, red blood cells, Bacillus subtilis, Bacillus amyloliquefaciens

1. Bezkorovainy A., Kot E. Interaction of Bifidobacteria with ferric iron, International Dairy Journal, 1998, Vol. 8 (5–6), pp. 507–512.

2. Russkij E. B., Glushenkova Yu.A., Telyshevskaya L. Ya., Noschevnyj V. T. Rol» i znachimost» ionov zheleza v pitanii i metabolizme mikroorganizmov, Novye informacionnye tehnologii v medicine, biologii, farmakologii i ekologii, 2007, Gurzuf, pp. 114–119. (In Russ.)

3. Kumar O., Sugendran K., Vijayaraghavan R. Oxidative stress associated hepatic and renal toxicity induced by ricin in mice, Toxicon, 2003, Vol. 41 (3), pp. 333–338.

4. Seledtsov V. I., Seledtsova G. V., Samarin D. M. Erythroid cells in suppressing leukemia cell growth, Leukemia and Lymphoma, 2005, Vol. 46 (9), pp. 1353–1356.

5. Girndt M., Stenvinkel P., Ulrich Ch. Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients, Nephrology Dialysis Transplantation, 2007, Vol. 22 (12), pp. 3586.

6. Arai M., Darmen J., Lewis A., Yamamoto J. K. The use of human hematopoietic growth factors (RHGM–CSF and RHEPO) as a supportive therapy for FIV-infected cats, Veterinary Immunology and Immunopathology, 2000, Vol. 77 (1–2), pp. 71–92.

7. Badenes R., Oddo M., Suarez J. I. Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey, Critical Care, 2017, Vol. 21 (1), pp. 159.

8. Sirdah M. M., Abu Shahla A. N.K., El-Agouza I.M.A. Possible ameliorative effect of taurine in the treatment of iron-deficiency anaemia in female university students of Gaza, Palestine, European Journal of Haematology, 2002, Vol. 69 (4), pp. 236–242.

9. Nazifi S., Tadjalli M., Bedeltavana A. R. Normal haematopoiesis, cellular components and stainable iron content in the bone marrow of camels (Camelus dromedarius), Veterinary Research Communications, 1998, Vol. 22 (1), pp. 11–20.

10. Areshidze D. A., Timchenko L. D., Gulyukin M. I. [et al.] Hepatoprotective effect of preparations produced from Chlorophytum comosum (l.) at experimental toxic damage in wistar rats, Pharmacologyonline, 2016, Vol. 2, pp. 81–90.

11. Tishkov S. N. Hronofarmakologicheskie pokszateli vliyaniya probioticheskogo preparata Vetom 1.23 na rabotosposobnost» zhivotyh, Vestn. NGAU, 2016, No 3 (40), pp. 144–151. (In Russ.)

12. Haziahmetov F. C., Habirov A. F., Kamil’yanov A. A. Morfo-biohimicheskie pokazateli krovi jagnjat I gusjat-brojlerov pri ispol’zovanii probiotikov Vitafort i Laktobifadol, Vestn. BGAU, 2016, No. 2, pp. 59–64. (In Russ.)

13. Shatova T. A., Tishkov S. N., Nozdrin G. A. Terapevticheckaja effektivnoct» primenenija probioticheskogo preparata Vetom 1 pri diareynom syndrome u teljat v ZAO Lebedevskoe Iskitimskogo rayona Novosibirskoj oblasti, Aktual’nye problem agropromyshlennogo kompleksa (Actual problems of the agro-industrial complex), Proceeding of Scientific and Practical Conference, Novosibirsk, 2016, pp. 432–434. (In Russ.)

14. Nozdrin G. A., Val’ter E.A., Nozdrin A. G. Gematologicheskie pokazateli krovi teljat pri primenenii preparata Vetom 1 na osnove atatogennyh bacill, Rol» agrarnoj nauki v ustojchivom razvitii sel’skih territorij (The role of agricultural science in the sustainable development of rural areas), Proceeding of International Scientific and Practical Conference, Novosibirsk, 2018, pp. 766–768. (In Russ.)

15. Shchepetkina S. V., Rishko O. A. Celesoosraznost» primenenija probiotikov u raznyh vidov zhivotnyh, Innovacii v APK: problem I perspektivy, 2017, No. 16 (4), pp. 203–212. (In Russ.)